Small Molecules

09 Jan 2007 Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 Trial of Its Novel Antifolate PDX in Patients With Peripheral T-cell Lymphoma
09 Jan 2007 Quatrx Pharmaceuticals Reports Positive Results From A Phase 2 Trial Of Fispemifene
09 Jan 2007 Xanthus Receives Orphan Drug Designation of Xanafide for the Treatment Of AML
09 Jan 2007 ProEthic Pharmaceuticals Announces Positive Phase III Clinical Trial Results for Fast-Acting Migraine Product Candidate
09 Jan 2007 Targacept Initiates Phase I Clinical Trial of TC-2216
09 Jan 2007 TaiGen Initiates Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
09 Jan 2007 Rigel Announces Initiation of Phase II Study Evaluating R788 in Immune Thrombocytopenic Purpura (ITP)
09 Jan 2007 Horizon Therapeutics Announces Special Protocol Assessment With Fda For Phase 3 Trial Program
08 Jan 2007 INNOVIVE Pharmaceuticals Announces Receipt of FDA Orphan Drug Designation for INNO-406 for the Treatment of Chronic Myelogenous Leukemia
06 Jan 2007 OSI Pharmaceuticals Licenses Its Glucokinase Activator Program for the Treatment of Type 2 Diabetes to Eli Lilly and Company
06 Jan 2007 Hypnion, Inc. Announces Positive And Robust Phase II Results For Novel Sleep Drug - HY10275
06 Jan 2007 TargeGen Selects Jak2 Inhibitor Lead (TG101348) for Clinical Development as a Potential Therapy for Myeloproliferative Diseases Including Polycythemia Vera (PV)
05 Jan 2007 Medivir Files Clinical Trial Application To Start Phase I With MIV-701
05 Jan 2007 Roche and Synosis Therapeutics Announce Partnership to Explore Potential of Five Compounds Targeting the Central Nervous System
05 Jan 2007 Pharmacopeia Enters into a Research and License Agreement with Wyeth to Develop Novel JAK3 Inhibitors for the Treatment of Immunological and Inflammatory Diseases
05 Jan 2007 Alkermes and Indevus Announce Joint Collaboration to Develop Inhaled Formulation of Trospium Chloride for the Treatment of COPD
05 Jan 2007 Oscient Pharmaceuticals and Menarini Group Enter into European Commercialization Agreement for FACTIVE Tablets
05 Jan 2007 Sunesis Out-Licenses LFA-1 Program to SARcode Corporation
05 Jan 2007 AVEO acquires Clinical Stage Anti-Cancer Compound from Kirin
05 Jan 2007 Sound Pharmaceuticals Announces the Successful Completion of its Phase I Clinical Trial for SPI-1005
05 Jan 2007 BiPar Sciences Begins Enrollment in Phase 1b Study of BSI-201
05 Jan 2007 Neosil Announces Positive Phase 2 Data for NEOSH101, an Investigational Treatment for Androgenetic Alopecia
05 Jan 2007 Enzon Pharmaceuticals Files Investigational New Drug Application for Novel HIF-1alpha Antagonist in Cancer
05 Jan 2007 BioMarin Initiates Phase 2 Clinical Study of 6R-BH4 in Peripheral Arterial Disease
04 Jan 2007 Cytokinetics and Amgen Announce Strategic Alliance in Heart Failure

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up